V. Mohan chosen for EASD Diabetes Global Impact Prize
The European Association for the Study of Diabetes (EASD)'s committee for the Diabetes Global Impact Prize has chosen V. Mohan, diabetologist and chairman, Dr. Mohan's Diabetes Specialities Centre and Madras Diabetes Research Foundation, as the first awardee and lecturer of the EASD Diabetes Global Impact Prize 2025. The award is in recognition of his contributions in clinical/translational research on diabetes that have had a global impact. As a part of this, Dr. Mohan will also deliver the first Diabetes Global Prize Lecture at the 61st EASD Annual Meeting scheduled to be held from September 15 to 19 at Vienna in Austria.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 days ago
- Time of India
‘New medicines help reverse heart failure in 1 of 4 patients'
1 2 3 Nagpur: New medicines are proving so effective that in about 25% of patients battling heart failure, the heart's pumping power can be restored to normal. "Heart failure is no longer a hopeless condition. With newer medicines, around a quarter of heart failure cases are reversible. This means the heart's pumping capacity can be regained. Moreover, in about 50% of patients, we can now control heart failure very effectively," said Dr JC Mohan, a leading cardiologist in India and key speaker at the Annual ECHO Nagpur 2025 Conference. Dr Mohan explained that heart failure is different from a heart attack. A heart attack is a sudden event in which a blockage cuts off the blood supply to the heart muscles. Heart failure, on the other hand, develops over time when the heart's ability to pump blood becomes weak, making it hard for the body to get enough oxygen. "Nearly 1% of India's adult population — about one crore people — are living with heart failure. Unfortunately, it has a worse outcome than many cancers because it often goes unrecognised, underestimated, and untreated," Dr Mohan said. He cautioned that people with diabetes and high blood pressure are at higher risk and urged early detection through regular check-ups. "With modern medicines, patients can live six to eight years longer than before. The key is early diagnosis and proper treatment. Simple tests like an ECHO (heart ultrasound), ECG, and certain blood tests help us detect heart failure early and start treatment before it's too late," Dr Mohan added. Dr Vinod Vijan, former president of Lipid Association of India, also shared crucial advice: "Indians should aim for cholesterol levels at least 10 points lower than global standard values because we are genetically more prone to heart diseases," he said. Dr Shantanu Sengupta, programme director for ECHO Nagpur 2025, said the past two decades have witnessed a big change in people's awareness. "This is the 21st year of ECHO in Nagpur, and today, common people know about it. ECHO has become as routine as ECG for diagnosing heart problems. 2D and 3D ECHO tests are giving doctors excellent information to detect heart diseases early. Everyone above 40 years should include ECHO in their regular health check-ups," Dr Sengupta recommended. About Heart Failure - Heart failure is a condition in which the heart can't pump blood strongly enough to meet the body's needs - It's different from a heart attack, which is a sudden blockage in heart blood flow - Nearly 1 crore people in India live with heart failure, often undiagnosed - The prognosis is serious—worse than many cancers - New medicines can reverse heart failure in about 25% of patients, restoring heart pumping power
Economic Times
5 days ago
- Economic Times
Novo Nordisk's Wegovy enters India: Can this weight loss jab beat Mounjaro? Price, who can use it & how it works
Novo Nordisk has launched Wegovy, a weight loss injection, in India, challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy contains semaglutide, mimicking a hormone to control blood sugar and reduce hunger. Priced from Rs 17,345 to Rs 26,015 monthly, it showed significant weight loss in trials. Tired of too many ads? Remove Ads India's obesity market is growing fast Tired of too many ads? Remove Ads How Wegovy Works Wegovy India Price List Dose Monthly Price (Rs) Price Per Dose (Rs) 0.25 mg Rs 17,345 Rs 4,366 0.5 mg Rs 17,345 Rs 4,366 1 mg Rs 17,345 Rs 4,366 1.75 mg Rs 24,280 Rs 6,070 2.4 mg Rs 26,015 Rs 6,503 Mounjaro Dose Monthly Price (Rs) 2.5 mg Rs 14,000 5 mg Rs 17,500 Almost like weight loss surgery, but with a catch Wegovy vs Mounjaro: What's the Difference? Feature Wegovy (Semaglutide) Mounjaro (Tirzepatide) How it works Mimics GLP-1 hormone Acts on GLP-1 and GIP hormones Effect Lowers appetite, slows digestion Improves insulin and reduces appetite Approved for Weight loss Diabetes (off-label for weight loss) How to use Weekly injection via Flexpen Weekly injection via vial Price range Rs 17,345–Rs 26,015 Rs 14,000–Rs 17,500 In a big step for India's weight loss drug market, Danish pharmaceutical company Novo Nordisk has officially launched Wegovy , its much-talked-about weight loss injection. The company is now competing directly with Eli Lilly's popular drug, Mounjaro Wegovy is a once-a-week injection that comes in a pen-like device called FlexTouch. It's easy to use and doesn't require vials or syringes. According to Managing Director of Novo Nordisk India, Vikrant Shrotriya, the drug will be available in pharmacies across India by the end of June 2025, The Times of India has one of the world's highest numbers of people struggling with weight. Around 254 million people have general obesity and over 351 million suffer from belly fat-related issues. With the anti-obesity medicine market jumping from Rs 133 crore in 2021 to Rs 576 crore today (as per PharmaTrac), Novo Nordisk sees a huge said, 'Obesity is a chronic illness and a growing problem in India. Wegovy is easy to use and will be priced specially for Indian patients.'Wegovy contains a compound called semaglutide , which mimics a natural hormone in the body. This hormone helps control blood sugar, reduce hunger, slow digestion, and make you feel full for longer. While similar drugs like Ozempic are meant for diabetes, Wegovy is approved for long-term weight comes in a FlexTouch device, allowing users to adjust their weekly dose easily. Each monthly pack includes four needles. The medicine works on brain areas that manage appetite and food to Dr V. Mohan, a well-known diabetologist, 'Semaglutide not only helps in weight loss but also improves heart and inflammation markers. It's a strong option for Indian patients dealing with both obesity and rising heart risks.'For comparison, Eli Lilly's Mounjaro is slightly cheaper:Wegovy has shown very strong results. In global studies, people lost up to 15% of their weight on average, and some even lost 20%. It also helped lower the risk of heart attacks and strokes and improved liver the results are mostly maintained only if the person continues using the drug. If stopped, weight gain can return. Doctors also warn that muscle loss may happen over time, so people need to be regularly from TOI
Indian Express
19-06-2025
- Indian Express
Drink black coffee daily? You can live longer with it, says study
A cup of black coffee every morning may just be adding years to your life. A large-scale study by Tufts University, US, claims that drinking one to three cups of coffee daily can reduce all-cause mortality, particularly from cardiovascular causes. However, there's a catch: the benefits hold only when you are not adding sugar, flavourings or cream. The study, which tracked subjects 1999 onwards, found that black coffee and coffee with very low levels of added sugar and saturated fat were associated with a 14 per cent lower risk of all-cause mortality as compared to zero coffee consumption. The same link was not observed for coffee with high amounts of added sugar and saturated fat. Drinking one cup per day was associated with a 16% lower risk of all-cause mortality. At 2-3 cups per day, the risk lowered by 17%. Consumption beyond three cups per day was not associated with additional reductions. In fact, the link between coffee and a lower risk of death from cardiovascular disease weakened in those who drank more than three cups per day. Why is the study significant? Research on the benefits of caffeine, such as improved attention, appetite suppression, alertness and physical performance have been many. But this is the first which specifies the type of coffee — black — to be had and by how much. Since a typical cup of coffee (240 ml) provides approximately 100 mg caffeine, drinking up to two cups are safe. This is also in line with an earlier study which found that individuals who drink coffee and sit for over six hours daily have lower mortality rates than non-coffee drinkers who sit for similar periods. What's the big problem with coffee studies? Dr V Mohan, Chairman, Dr Mohan's Diabetes Specialities Centre, Chennai, feels the problem with studies on coffee drinking is that none tell you that the results depend on several variables, like the kind of coffee taken, its amount and how it is consumed. 'For example, in the West, they have their coffee black but in India, it is made with milk and sugar. The role of artificial sweeteners is still not ascertained. A few human studies suggest they are safe but animal studies have linked them to obesity, an increased risk of Type 2 diabetes and changes in gut microbiota of mice,' he says. Then there are many kinds of coffee, dilute, concentrated, Arabic, decaffeinated, caffeinated, all of which have different effects. 'In India, we also have coffee with different foods. In such a scenario, how do you tease out the effects of coffee?' he asks. Is black coffee good for diabetes? Only in moderation. One or two cups a day usually don't cause problems. 'But having five or six cups can backfire, especially when you're not sleeping enough. High caffeine intake increases adrenaline and cortisol levels, just like lack of sleep does. Together, they create a double impact on your glucose control. So, caffeine indirectly raises your blood sugar, too. Plus, excessive caffeine can lead to poor sleep quality — even if you do manage to get to bed on time. It becomes a cycle: less sleep, more coffee, more stress hormones, and higher blood sugar,' says Dr Mohan. The ideal combination Try reducing your caffeine to two cups a day — preferably before 2 pm. 'Then monitor your blood sugar. You'll likely see improvement within a week or two,' says Dr Mohan.
